Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Structural features of coronavirus SARS-CoV-2 spike protein: Targets for vaccination
Ariane Sternberg, Cord Naujokat
Life Sciences (2020) Vol. 257, pp. 118056-118056
Open Access | Times Cited: 222

Showing 1-25 of 222 citing articles:

SARS-CoV-2: Structure, Biology, and Structure-Based Therapeutics Development
Mei-Yue Wang, Rong Zhao, Lijuan Gao, et al.
Frontiers in Cellular and Infection Microbiology (2020) Vol. 10
Open Access | Times Cited: 836
Omicron and Delta variant of SARS‐CoV‐2: A comparative computational study of spike protein
Suresh Kumar, Thiviya S. Thambiraja, Kalimuthu Karuppanan, et al.
Journal of Medical Virology (2021) Vol. 94, Iss. 4, pp. 1641-1649
Open Access | Times Cited: 522
Ad26 vector-based COVID-19 vaccine encoding a prefusion-stabilized SARS-CoV-2 Spike immunogen induces potent humoral and cellular immune responses
Rinke Bos, Lucy Rutten, Joan E. M. van der Lubbe, et al.
npj Vaccines (2020) Vol. 5, Iss. 1
Open Access | Times Cited: 342
Epidemiology, pathogenesis, clinical presentations, diagnosis and treatment of COVID-19: a review of current evidence
Sayeeda Rahman, Maria Teresa Villagomez Montero, Kherie Rowe, et al.
Expert Review of Clinical Pharmacology (2021) Vol. 14, Iss. 5, pp. 601-621
Open Access | Times Cited: 258
SARS-CoV-2 Vaccines Based on the Spike Glycoprotein and Implications of New Viral Variants
Daniel Martínez-Flores, Jesús Zepeda–Cervantes, Adolfo Cruz-Reséndiz, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 219
Inhibitory activities of marine sulfated polysaccharides against SARS-CoV-2
Shuang Song, Haoran Peng, Qingling Wang, et al.
Food & Function (2020) Vol. 11, Iss. 9, pp. 7415-7420
Closed Access | Times Cited: 186
The SARS-CoV-2 nucleocapsid protein: its role in the viral life cycle, structure and functions, and use as a potential target in the development of vaccines and diagnostics
Wenbing Wu, Ying Cheng, Hong Zhou, et al.
Virology Journal (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 145
A critical review on SARS-CoV-2 infectivity in water and wastewater. What do we know?
Alexandre Giacobbo, Marco Antônio Siqueira Rodrigues, Jane Zoppas Ferreira, et al.
The Science of The Total Environment (2021) Vol. 774, pp. 145721-145721
Open Access | Times Cited: 119
Vitamin D Regulation of Immune Function
Daniel D. Bikle
Current Osteoporosis Reports (2022) Vol. 20, Iss. 3, pp. 186-193
Open Access | Times Cited: 91
The high infectivity of SARS-CoV-2 B.1.1.7 is associated with increased interaction force between Spike-ACE2 caused by the viral N501Y mutation
Jadson C. Santos, Geraldo Aleixo Silva Passos
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 103
Therapeutic targets and interventional strategies in COVID-19: mechanisms and clinical studies
Yuwen Zhou, Yao Xie, Liansha Tang, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 102
The role of cell surface sialic acids for SARS-CoV-2 infection
Xue‐Long Sun
Glycobiology (2021) Vol. 31, Iss. 10, pp. 1245-1253
Open Access | Times Cited: 98
Omicron and Delta Variant of SARS-CoV-2: A Comparative Computational Study of Spike protein
Suresh Kumar, Thiviya S. Thambiraja, Kalimuthu Karuppanan, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 92
SARS-CoV-2 spike protein: pathogenesis, vaccines, and potential therapies
Ahmed M. Almehdi, Ghalia Khoder, Aminah Alchakee, et al.
Infection (2021) Vol. 49, Iss. 5, pp. 855-876
Open Access | Times Cited: 91
Glycans of SARS-CoV-2 Spike Protein in Virus Infection and Antibody Production
Xiaohui Zhao, Huan Chen, Hongliang Wang
Frontiers in Molecular Biosciences (2021) Vol. 8
Open Access | Times Cited: 88
SARS-CoV-2 Infection: New Molecular, Phylogenetic, and Pathogenetic Insights. Efficacy of Current Vaccines and the Potential Risk of Variants
John Charles Rotondo, Fernanda Martini, Martina Maritati, et al.
Viruses (2021) Vol. 13, Iss. 9, pp. 1687-1687
Open Access | Times Cited: 75
Development of multivalent nanobodies blocking SARS-CoV-2 infection by targeting RBD of spike protein
Qizhong Lu, Zongliang Zhang, Hexian Li, et al.
Journal of Nanobiotechnology (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 72
Point of view on the vaccination against COVID-19 in patients with autoimmune inflammatory rheumatic diseases
Victoria Furer, Christien Rondaan, Nancy Agmon‐Levin, et al.
RMD Open (2021) Vol. 7, Iss. 1, pp. e001594-e001594
Open Access | Times Cited: 69
HLA variation and antigen presentation in COVID-19 and SARS-CoV-2 infection
Danillo G. Augusto, Jill A. Hollenbach
Current Opinion in Immunology (2022) Vol. 76, pp. 102178-102178
Open Access | Times Cited: 67
Impact of the SARS‐CoV‐2 virus on male reproductive health
Daniel E. Nassau, Jordan C. Best, Eliyahu Kresch, et al.
BJU International (2021) Vol. 129, Iss. 2, pp. 143-150
Open Access | Times Cited: 64
Site-Specific Steric Control of SARS-CoV-2 Spike Glycosylation
Joel D. Allen, Himanshi Chawla, Firdaus Samsudin, et al.
Biochemistry (2021) Vol. 60, Iss. 27, pp. 2153-2169
Open Access | Times Cited: 60
Microarray patches enable the development of skin-targeted vaccines against COVID-19
Emrullah Korkmaz, Stephen C. Balmert, Tina L. Sumpter, et al.
Advanced Drug Delivery Reviews (2021) Vol. 171, pp. 164-186
Open Access | Times Cited: 57
The role of cell death in SARS-CoV-2 infection
Cui Yuan, Zhenling Ma, Jiufeng Xie, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 40
Evolution of the SARS-CoV-2 Omicron spike
Ruth Parsons, Priyamvada Acharya
Cell Reports (2023) Vol. 42, Iss. 12, pp. 113444-113444
Open Access | Times Cited: 35
Immune Epitopes of SARS-CoV-2 Spike Protein and Considerations for Universal Vaccine Development
Nicholas Magazine, Tianyi Zhang, Anang D. Bungwon, et al.
ImmunoHorizons (2024) Vol. 8, Iss. 3, pp. 214-226
Open Access | Times Cited: 10
Page 1 - Next Page

Scroll to top